Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Heart Failure Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Biograd na Moru, Croatia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with diagnosed chronic heart failure
Patients treated for at least 6 months with candesartan cilexetil
Signed Informed consent

Exclusion criteria

Hypersensitivity to candesartan cilexetil
Pregnancy / lactation
Severe hepatic impairment

Treatment and study plan

Primary outcomes

To evaluate clinical signs and symptoms of chronic heart failure (in terms of NYHA status, fluid retention and tiredness/fatigue) after at least 6 months of treatment with candesartan cilexetil

Time frame: 1 visit (after at least 6 months of treatment)

Secondary outcomes

To evaluate ventricular function after at least 6 months of treatment with candesartan cilexetil

Time frame: 1 visit (after at least 6 months of treatment)
To gain insight into usage of candesartan cilexetil in real life for chronic heart failure in Croatia

Time frame: 1 visit (after at least 6 months of treatment)
To evaluate patient's compliance with prescribed treatment

Time frame: 1 visit (after at least 6 months of treatment)

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Sep 25, 2009
Registry last updated: Jan 7, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed